Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Quest To Acquire Celera Corp. | Contract Pharma

What are you searching for?

Sign in
Breaking News

Quest To Acquire Celera Corp.

Quest Diagnostics, Inc. will acquire Celera Corp. for $671 million, providing Quest with access to genetic tests and an R&D pipeline focused on cardiovascular disease and cancer.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quest Diagnostics, Inc. will acquire Celera Corp. for $671 million, providing Quest with access to genetic tests and an R&D pipeline focused on cardiovascular disease and cancer. The transaction is expected to close the end of April.

Celera focuses on sequencing the human genome and identifying links between genetic variations and disease states. Quest also recently announced plans to acquire the Athena Diagnostics business from Thermo Fisher Scientific Inc. for $740 million in cash. Athena is a provider of diagnostic tests for neurological conditions, including Alzheimer’s disease.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics